BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 2048715)

  • 1. An assay procedure for solubilized thyroid hormone receptor: use of Lipidex.
    Li Q; Yamamoto N; Inoue A; Morisawa S
    Anal Biochem; 1991 Jan; 192(1):138-41. PubMed ID: 2048715
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preparation of unoccupied thyroid-hormone receptor.
    Li Q; Inoue A
    Biochem J; 1994 Jan; 297 ( Pt 1)(Pt 1):75-8. PubMed ID: 7506534
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of assay procedures for solubilized thyroid hormone receptor.
    Yamakawa J
    Osaka City Med J; 1994 Dec; 40(2):71-81. PubMed ID: 7862428
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Filter-binding assay procedure for thyroid hormone receptors.
    Inoue A; Yamakawa J; Yukioka M; Morisawa S
    Anal Biochem; 1983 Oct; 134(1):176-83. PubMed ID: 6318596
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro 3,5,3'-triiodothyronine binding to rat cerebrocortical neuronal and glial nuclei suggests the presence of binding sites unavailable in vivo.
    Kolodny JM; Larsen PR; Silva JE
    Endocrinology; 1985 May; 116(5):2019-28. PubMed ID: 2985367
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro binding of L-triiodothyronine to receptors in rat liver nuclei. Kinectics of binding, extraction properties, and lack of requirement for cytosol proteins.
    Surks MI; Koerner DH; Oppenheimer JH
    J Clin Invest; 1975 Jan; 55(1):50-60. PubMed ID: 162784
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of thyroid hormone receptors and responses by thyrotropin-releasing hormone in GH4C1 cells.
    Kaji H; Hinkle PM
    Endocrinology; 1987 Nov; 121(5):1697-704. PubMed ID: 3117521
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thyroid hormone receptors from liver nuclei: characteristics of receptor from normal, thyroidectomized, and triiodothyronine-treated rats; measurement of occupied and unoccupied receptors, and chromatin binding of receptors.
    Bernal J; Coleoni AH; DeGroot LJ
    Endocrinology; 1978 Aug; 103(2):403-13. PubMed ID: 217646
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of LiCl on triiodothyronine (T3) binding to nuclei from rat cerebral hemispheres.
    Bolaris S; Margarity M; Valcana T
    Biol Psychiatry; 1995 Jan; 37(2):106-11. PubMed ID: 7718673
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epidermal growth factor decreases thyroid hormone receptors and attenuates thyroid hormone responses in GH4C1 cells.
    Kaji H; Hinkle PM
    Endocrinology; 1987 Feb; 120(2):537-43. PubMed ID: 3492366
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition by rifamycin AF/013 of thyroid hormone binding to the nuclear receptor.
    Inoue A; Higashi Y; Yukioka M; Morisawa S
    J Biochem; 1987 Dec; 102(6):1365-70. PubMed ID: 3448087
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Physiochemical factors influencing the stability of solubilized liver nuclear receptor-3,5,3'-triiodothyronine complex in vitro.
    Brtko J; Knopp J; DeGroot LJ
    Endocrinol Exp; 1987 Dec; 21(4):251-6. PubMed ID: 3501978
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Desethylamiodarone is a noncompetitive inhibitor of the binding of thyroid hormone to the thyroid hormone beta 1-receptor protein.
    Bakker O; van Beeren HC; Wiersinga WM
    Endocrinology; 1994 Apr; 134(4):1665-70. PubMed ID: 8137729
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of chloral hydrate on the in-vitro T3 binding to adult rat cerebral nuclei.
    Bolaris S; Constantinou C; Valcana T; Margarity M
    J Pharm Pharmacol; 2005 Aug; 57(8):1011-8. PubMed ID: 16102257
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Unesterified long-chain fatty acids inhibit thyroid hormone binding to the nuclear receptor. Solubilized receptor and the receptor in cultured cells.
    Inoue A; Yamamoto N; Morisawa Y; Uchimoto T; Yukioka M; Morisawa S
    Eur J Biochem; 1989 Aug; 183(3):565-72. PubMed ID: 2776751
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Attenuation of thyroid hormone action by 1,25-dihydroxyvitamin D3 in pituitary cells.
    Kaji H; Hinkle PM
    Endocrinology; 1989 Feb; 124(2):930-6. PubMed ID: 2463908
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of adenosine triphosphate and alkaline phosphatase on solubilized 3,5,3'-triiodothyronine-binding activity.
    Faure R; Dussault JH
    Endocrinology; 1988 Sep; 123(3):1245-52. PubMed ID: 3402384
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nuclear triiodothyronine receptor binding characteristics and occupancy in obese (ob/ob) mice.
    Hillgartner FB; Romsos DR
    Am J Physiol; 1987 Mar; 252(3 Pt 1):E414-9. PubMed ID: 3826366
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Steady state model of 3,5,3'-triiodothyronine transport in liver predicts high cellular exchangeable hormone concentration relative to in vitro free hormone concentration.
    Pardridge WM; Landaw EM
    Endocrinology; 1987 Mar; 120(3):1059-68. PubMed ID: 3803309
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Binding of thyroid hormones to nuclear extracts of thyroid cells.
    Erkenbrack DE; Rosenberg LL
    Endocrinology; 1986 Jul; 119(1):311-7. PubMed ID: 3013592
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.